CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China · Delayed Price · Currency is CNY 5.17
+0.04 (0.78%)
Oct 28, 2026, 3:04 PM CST
SHE:000908 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 160.23 | 75.6 | 85.52 | 13.17 | 181.39 | 172.18 |
Cash & Short-Term Investments | 1,641 | 75.6 | 85.52 | 13.17 | 181.39 | 172.18 |
Cash Growth | 6175.57% | -11.61% | 549.63% | -92.74% | 5.35% | 4.86% |
Accounts Receivable | 91.05 | 61.59 | 70.13 | 85.92 | 197.02 | 217.24 |
Other Receivables | 85.14 | 86.03 | 15.33 | 31.95 | 27.16 | 91.22 |
Receivables | 176.19 | 147.62 | 85.46 | 117.86 | 224.18 | 308.46 |
Inventory | 61.84 | 38.83 | 44.18 | 64.58 | 120.37 | 155.4 |
Other Current Assets | 24.28 | 13.3 | 12.03 | 18.15 | 45.35 | 41.48 |
Total Current Assets | 1,903 | 275.35 | 227.19 | 213.76 | 571.3 | 677.51 |
Property, Plant & Equipment | 325.38 | 316.27 | 328.67 | 434.21 | 553.48 | 726.1 |
Long-Term Investments | 51.17 | 51.29 | 210.94 | 44.72 | 50.46 | 103.86 |
Goodwill | - | - | 0.12 | 0.12 | 33.03 | 33.03 |
Other Intangible Assets | 59.15 | 64.18 | 53.45 | 61.55 | 101.66 | 100.47 |
Long-Term Deferred Tax Assets | 3.53 | 4.29 | 2.49 | 10.41 | 30.3 | 23.57 |
Long-Term Deferred Charges | 106.69 | 98.41 | 111.12 | 107.86 | 106.49 | 117.4 |
Other Long-Term Assets | 12.75 | 10.15 | 6.01 | 187.72 | 10.82 | 10.36 |
Total Assets | 2,462 | 819.95 | 939.98 | 1,060 | 1,458 | 1,792 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 92.34 | 107.92 | 102.96 | 148.94 | 138.54 | 122.97 |
Accrued Expenses | 4.2 | 46.48 | 53.45 | 105.76 | 109.51 | 63.29 |
Short-Term Debt | - | 9.76 | 191.67 | 195.82 | 213.02 | 475.67 |
Current Portion of Long-Term Debt | 1.29 | 76.18 | 260.9 | 299.42 | 299.8 | 387.68 |
Current Portion of Leases | - | 1.49 | 11.46 | 3.67 | 3.63 | 1.3 |
Current Income Taxes Payable | 20.97 | 10.46 | 2.46 | 0.62 | 4.93 | 1.17 |
Current Unearned Revenue | 12.06 | 15.69 | 16.28 | 24.19 | 26.2 | 25.22 |
Other Current Liabilities | 268.23 | 533.57 | 265.56 | 263.12 | 287.71 | 283.8 |
Total Current Liabilities | 399.08 | 801.56 | 904.73 | 1,042 | 1,083 | 1,361 |
Long-Term Debt | - | - | - | 72.28 | 72.52 | 1 |
Long-Term Leases | 5.44 | 5.88 | 6.71 | 22.69 | 9.84 | 7.87 |
Long-Term Unearned Revenue | 10.89 | 13.58 | 17.15 | 20.73 | 24.81 | 51.01 |
Long-Term Deferred Tax Liabilities | 0.07 | 0.84 | 2.91 | 7.7 | 6.45 | 5.27 |
Other Long-Term Liabilities | 12.76 | 26.35 | 23.61 | 70.04 | 58.93 | 38.34 |
Total Liabilities | 428.26 | 848.2 | 955.11 | 1,235 | 1,256 | 1,465 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,296 | 416.69 | 416.69 | 416.69 | 416.69 | 416.69 |
Additional Paid-In Capital | 1,843 | 639.91 | 617.75 | 617.75 | 617.75 | 617.42 |
Retained Earnings | -1,010 | -1,015 | -933.99 | -1,086 | -850.2 | -708.89 |
Comprehensive Income & Other | -18.39 | -18.57 | -18.65 | -18.59 | -19.46 | -18.83 |
Total Common Equity | 2,088 | 23.14 | 81.8 | -70.45 | 164.79 | 306.39 |
Minority Interest | -54.82 | -51.39 | -96.93 | -104.19 | 36.85 | 21.34 |
Shareholders' Equity | 2,033 | -28.25 | -15.13 | -174.64 | 201.63 | 327.73 |
Total Liabilities & Equity | 2,462 | 819.95 | 939.98 | 1,060 | 1,458 | 1,792 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 6.73 | 93.32 | 470.74 | 593.88 | 598.81 | 873.52 |
Net Cash (Debt) | 1,634 | -17.72 | -385.22 | -580.72 | -417.42 | -701.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 1.19 | -0.02 | -0.44 | -0.66 | -0.47 | -0.80 |
Filing Date Shares Outstanding | 1,801 | 1,760 | 879.77 | 879.77 | 879.77 | 879.77 |
Total Common Shares Outstanding | 1,801 | 879.77 | 879.77 | 879.77 | 879.77 | 879.77 |
Working Capital | 1,504 | -526.2 | -677.54 | -827.79 | -512.06 | -683.57 |
Book Value Per Share | 1.16 | 0.03 | 0.09 | -0.08 | 0.19 | 0.35 |
Tangible Book Value | 2,029 | -41.04 | 28.23 | -132.12 | 30.1 | 172.89 |
Tangible Book Value Per Share | 1.13 | -0.05 | 0.03 | -0.15 | 0.03 | 0.20 |
Buildings | - | 267.57 | 267.57 | 337.65 | 401.86 | 527.56 |
Machinery | - | 267.36 | 280.5 | 291.5 | 412.21 | 385.78 |
Construction In Progress | - | 72.99 | 70.22 | 70.22 | 88.37 | 87.72 |